| References |
|
|
Arvin AM
(2006)
Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
Herpes
13:
75–80.
|
|
|
Barrett-Muir W,
Scott FT,
Aaby P et al.
(2003)
Genetic variation of Varicella-zoster virus: evidence for geographical separation of strains.
Journal of Medical Virology
70:
S42–S47.
|
|
|
book
Breuer J
(2004)
"Varicella Zoster".
In: Zuckerman AJ,
Banatvala JE and
Pattison JR et al. (eds)
Principles and Practice of Clinical Virology,
5th edn,
pp. 53–83.
England: Wiley.
|
|
|
Chapman SJ
(1998)
Varicella in pregnancy.
Seminars in Perinatology
22:
339–346.
|
|
|
Enders G
(1985)
Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test.
Postgraduate Medical Journal
61:
23–30.
|
|
|
other
Cohen JI ,
Straus SE and
Arvin AM
(2007) Varicella zoster virus, Fields Virology. In: Knipe DM and Howley PM (editors in chief) Griffin DE, Lamb RA, Martin MA, Roizman B and Straus SE (associate editors), 5th edn, pp. 2773–2818. Philadelphia: Lippincott Williams & Wilkins.
|
|
|
Faga B,
Maury W,
Bruckner DA and
Grose C
(2001)
Identification and mapping of single nucleotide polymorphisms in the Varicella-zoster virus genome.
Virology
280:
1–6.
|
|
|
Grose C
(2005)
Varicella vaccination of children in the United States: assessment after the first decade 1995–2005.
Journal of Clinical Virology
33:
89–95. discussion 96–98.
|
|
|
Hambleton S and
Gershon AA
(2005)
The impact of varicella vaccination in the United States.
Seminars in Pediatric Infectious Diseases
16:
38–43.
|
|
|
Hayward A,
Levin M,
Wolf W,
Angelova G and
Gilden D
(1991)
Varicella-zoster virus-specific immunity after herpes zoster.
Journal of Infectious Diseases
163:
873–875.
|
|
|
Loparev VN,
Gonzalez A,
Deleon-Carnes M et al.
(2004)
Global identification of three major genotypes of Varicella-zoster virus: longitudinal clustering and strategies for genotyping.
Journal of Virology
78:
8349–8358.
|
|
|
Loparev VN,
Rubtcova EN,
Bostik V et al.
(2007)
Identification of five major and two minor genotypes of Varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand.
Journal of Virology
81:
12758–12765.
|
|
|
McGeoch DJ,
Rixon FJ and
Davison AJ
(2006)
Topics in herpesvirus genomics and evolution.
Virus Research
117:
90–104.
|
|
|
Quinlivan M and
Breuer J
(2005)
Molecular and therapeutic aspects of varicella-zoster virus infection.
Expert Reviews in Molecular Medicine
7:
1–24.
|
|
|
Quinlivan M and
Breuer J
(2006)
Molecular studies of Varicella zoster virus.
Reviews in Medical Virology
16:
225–250.
|
|
|
Quinlivan M,
Hawrami K,
Barrett-Muir W et al.
(2002)
The molecular epidemiology of Varicella-zoster virus: evidence for geographic segregation.
Journal of Infectious Diseases
186:
888–894.
|
|
|
Quinlivan ML,
Gershon AA,
Steinberg SP and
Breuer J
(2004)
Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.
Journal of Infectious Diseases
190:
793–796.
|
|
|
Quinlivan ML,
Gershon AA,
Nichols RA et al.
(2006)
Vaccine Oka Varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
Journal of Infectious Diseases
193:
927–930.
|
|
|
Quinlivan ML,
Gershon AA,
Al Bassam MM et al.
(2007)
Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts.
Proceedings of the National Academy of Science of the USA
104:
208–212.
|
|
|
Wagenaar TR,
Chow VTK,
Buranathai C,
Thawatsupha P and
Grose C
(2003)
The out of Africa model of Varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades.
Vaccine
21:
1072–1081.
|
|
|
book
Whitley RJ
(2000)
"Varicella-zoster infections".
In: Mandell GL,
Bennett JE and
Dolin R (eds)
Principles and Practice of Infectious Diseases,
pp. 1580–1586.
Philadelphia, PA: Churchill Livingstone Inc.
|
| Further Reading |
|
|
Abendroth A and
Arvin A
(2001)
Immune evasion mechanisms of varicella-zoster virus.
Archives of virology. Supplementum
17:
99–107.
|
|
|
Arvin AM
(2002)
Antiviral therapy for varicella and herpes zoster.
Seminars in Pediatric Infectious Diseases
13:
12–21.
|
|
|
Dworkin RH,
Johnson RW,
Breuer J et al.
(2007)
Recommendations for the management of herpes zoster.
Clinical Infectious Diseases
44:
S1–S26.
|
|
|
Gardella C and
Brown ZA
(2007)
Managing varicella zoster infection in pregnancy.
Cleveland Clinic Journal of Medicine
74:
290–296.
|
|
|
Grose C
(2006)
Varicella zoster virus: out of Africa and into the research laboratory.
Herpes
13:
32–36.
|
|
|
Hambleton S
(2005)
Chickenpox.
Current Opinion in Infectious Diseases
18:
235–240.
|
|
|
Hambleton S,
Gershon MD and
Gershon AA
(2004)
The role of the trans-Golgi network in Varicella zoster virus biology.
Cellular and Molecular Life Sciences
61:
3047–3056.
|
|
|
Oxman MN,
Levin MJ,
Johnson GR et al.
(2005)
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
New England Journal of Medicine
352:
2271–2284.
|
|
|
Sengupta N,
Booy R,
Schmitt HJ et al.
(2007)
Varicella vaccination in Europe: are we ready for a universal childhood programme?
European Journal of Paediatrics
167:
47–55.
|
|
|
Weaver BA
(2007)
The burden of herpes zoster and postherpetic neuralgia in the United States.
The Journal of the American Osteopathic Association
107:
S2–S7.
|
